Literature DB >> 11252606

A marginal likelihood approach for estimating penetrance from kin-cohort designs.

N Chatterjee1, S Wacholder.   

Abstract

The kin-cohort design is a promising alternative to traditional cohort or case-control designs for estimating penetrance of an identified rare autosomal mutation. In this design, a suitably selected sample of participants provides genotype and detailed family history information on the disease of interest. To estimate penetrance of the mutation, we consider a marginal likelihood approach that is computationally simple to implement, more flexible than the original analytic approach proposed by Wacholder et al. (1998, American Journal of Epidemiology 148, 623-629), and more robust than the likelihood approach considered by Gail et al. (1999, Genetic Epidemiology 16, 15-39) to presence of residual familial correlation. We study the trade-off between robustness and efficiency using simulation experiments. The method is illustrated by analysis of the data from the Washington Ashkenazi Study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11252606     DOI: 10.1111/j.0006-341x.2001.00245.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  23 in total

1.  Colorectal cancer risk in monoallelic carriers of MYH variants.

Authors:  Emily L Webb; Mathew F Rudd; Richard S Houlston
Journal:  Am J Hum Genet       Date:  2006-10       Impact factor: 11.025

2.  Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.

Authors:  Bhramar Mukherjee; John Oliver Delancey; Leon Raskin; Jessica Everett; Joanne Jeter; Colin B Begg; Irene Orlow; Marianne Berwick; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Hoda Anton Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Lynn From; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2012-04-24       Impact factor: 13.506

3.  Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies.

Authors:  Mitchell H Gail
Journal:  Lifetime Data Anal       Date:  2007-12-06       Impact factor: 1.588

Review 4.  Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers.

Authors:  Janet R Vos; Li Hsu; Richard M Brohet; Marian J E Mourits; Jakob de Vries; Kathleen E Malone; Jan C Oosterwijk; Geertruida H de Bock
Journal:  J Clin Oncol       Date:  2015-07-06       Impact factor: 44.544

5.  Statistical inference on the penetrances of rare genetic mutations based on a case-family design.

Authors:  Hong Zhang; Sylviane Olschwang; Kai Yu
Journal:  Biostatistics       Date:  2010-02-23       Impact factor: 5.899

6.  Breast cancer after chest radiation therapy for childhood cancer.

Authors:  Chaya S Moskowitz; Joanne F Chou; Suzanne L Wolden; Jonine L Bernstein; Jyoti Malhotra; Danielle Novetsky Friedman; Nidha Z Mubdi; Wendy M Leisenring; Marilyn Stovall; Sue Hammond; Susan A Smith; Tara O Henderson; John D Boice; Melissa M Hudson; Lisa R Diller; Smita Bhatia; Lisa B Kenney; Joseph P Neglia; Colin B Begg; Leslie L Robison; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2014-04-21       Impact factor: 44.544

7.  Estimating gene penetrance from family data.

Authors:  Gail Gong; Nathan Hannon; Alice S Whittemore
Journal:  Genet Epidemiol       Date:  2010-05       Impact factor: 2.135

8.  Semiparametric inference on the penetrances of rare genetic mutations based on a case-family design.

Authors:  Hong Zhang; Donglin Zeng; Sylviane Olschwang; Kai Yu
Journal:  J Stat Plan Inference       Date:  2013-02       Impact factor: 1.111

9.  A frailty-model-based approach to estimating the age-dependent penetrance function of candidate genes using population-based case-control study designs: an application to data on the BRCA1 gene.

Authors:  Lu Chen; Li Hsu; Kathleen Malone
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

10.  Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.

Authors:  Alice J Sigurdson; Michael Hauptmann; Nilanjan Chatterjee; Bruce H Alexander; Michele Morin Doody; Joni L Rutter; Jeffery P Struewing
Journal:  BMC Cancer       Date:  2004-03-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.